“Spine is more of a surgical business, and the strategy has been simple,” Mr. Martha said, as transcribed by Seeking Alpha. “It’s taken some time to do this, but shift it from implant-driven to, on the terms of competitive dynamics, to enabling technology, technology-driven. So, robotics, navigation, interoperative imaging, powered instruments, AI-based surgical plans, all integrated together to take a spine surgery from an art to a science, take variable outcomes to make them less variable, take average surgeons, make them good surgeons.”
Mr. Martha said its spine technologies built a strong moat around the company’s business and is surpassing its competitors.
“We have a 10,000-unit installed base globally of this large capital, whether it’d be robots, imaging, navigation,” he said. “That’s four times our biggest competitor.”
The company is coming off of a strong fiscal year 2024 with $32.4 billion, an increase of 3.6% year-over-year. On top of that, Medtronic saw a full-year net income of $3.7 billion.
